Published in Epilepsia on November 01, 2006
Therapeutic devices for epilepsy. Ann Neurol (2012) 1.50
Technology insight: neuroengineering and epilepsy-designing devices for seizure control. Nat Clin Pract Neurol (2008) 1.28
How do seizures stop? Epilepsia (2008) 1.25
Convection-enhanced delivery in the treatment of epilepsy. Neurotherapeutics (2009) 1.08
Evolution and prospects for intracranial pharmacotherapy for refractory epilepsies: the subdural hybrid neuroprosthesis. Epilepsy Res Treat (2010) 0.87
Toward new paradigms of seizure detection. Epilepsy Behav (2012) 0.82
In vivo imaging of epileptic foci in rats using a miniature probe integrating diffuse optical tomography and electroencephalographic source localization. Epilepsia (2014) 0.77
De novo mutations in epileptic encephalopathies. Nature (2013) 7.42
Sleep duration among black and white Americans: results of the National Health Interview Survey. J Natl Med Assoc (2008) 3.82
Anterior temporal lobectomy with amygdalohippocampectomy for mesial temporal sclerosis: predictors of long-term seizure control. J Neurosurg (2013) 3.29
A developmental and genetic classification for malformations of cortical development: update 2012. Brain (2012) 3.14
Magnetic source imaging versus intracranial electroencephalogram in epilepsy surgery: a prospective study. Ann Neurol (2006) 2.64
The human K-complex represents an isolated cortical down-state. Science (2009) 2.54
Cannabinoids in the Treatment of Epilepsy. N Engl J Med (2015) 2.27
Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCN1A. J Neurosci (2003) 1.77
Heterogeneous neuronal firing patterns during interictal epileptiform discharges in the human cortex. Brain (2010) 1.62
Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy. Arch Neurol (2003) 1.60
Health-related quality of life over time since resective epilepsy surgery. Ann Neurol (2007) 1.59
Race/ethnicity, sex, and socioeconomic status as predictors of outcome after surgery for temporal lobe epilepsy. Arch Neurol (2006) 1.55
Epilepsy surgery for children with tuberous sclerosis complex. J Child Neurol (2004) 1.52
Selective emotional detachment from family after right temporal lobectomy. Epilepsy Behav (2003) 1.47
Impaired consciousness in temporal lobe seizures: role of cortical slow activity. Brain (2010) 1.44
Slow cortical dynamics and the accumulation of information over long timescales. Neuron (2012) 1.42
The excitable cerebral cortex Fritsch G, Hitzig E. Uber die elektrische Erregbarkeit des Grosshirns. Arch Anat Physiol Wissen 1870;37:300-32. Epilepsy Behav (2009) 1.42
Neuroinflammation and psychiatric illness. J Neuroinflammation (2013) 1.42
Do tubers contain function? Resection of epileptogenic foci in perirolandic cortex in children with tuberous sclerosis complex. Epilepsia (2010) 1.39
Epilepsy surgery in young children with tuberous sclerosis: results of a novel approach. Pediatrics (2006) 1.37
The epilepsy phenome/genome project. Clin Trials (2013) 1.32
The treatment of nonepileptic seizures: historical perspectives and future directions. Epilepsia (2004) 1.24
Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of response. Epilepsy Behav (2010) 1.23
Cortical reorganization in malformations of cortical development: a magnetoencephalographic study. Neurology (2004) 1.23
Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease. Nutr Metab (Lond) (2006) 1.20
A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials. Epilepsy Behav (2003) 1.15
Epilepsy: is localization-related epilepsy a progressive disorder? Maybe... Nat Rev Neurol (2009) 1.14
Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patients. Epilepsia (2007) 1.12
Multimodal imaging of repetition priming: Using fMRI, MEG, and intracranial EEG to reveal spatiotemporal profiles of word processing. Neuroimage (2010) 1.09
Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J Neuroinflammation (2013) 1.08
Efficacy of vagus nerve stimulation over time: review of 65 consecutive patients with treatment-resistant epilepsy treated with VNS > 10 years. Epilepsy Behav (2011) 1.07
Kluver-Bucy syndrome, hypersexuality, and the law. Neurocase (2009) 1.06
Dexmedetomidine in awake craniotomy: a technical note. Surg Neurol (2005) 1.05
Detection of epileptogenic cortical malformations with surface-based MRI morphometry. PLoS One (2011) 1.05
Degree of handedness and cerebral dominance. Neurology (2006) 1.04
Current treatments of epilepsy. Neurology (2005) 1.04
Developmental brain abnormalities in tuberous sclerosis complex: a comparative tissue analysis of cortical tubers and perituberal cortex. Epilepsia (2014) 1.04
Evaluation of sleep apnea in a sample of black patients. J Clin Sleep Med (2008) 1.03
Evidence for cortical reorganization of language in patients with hippocampal sclerosis. Brain (2007) 1.02
Ictal SPECT analysis in epilepsy: subtraction and statistical parametric mapping techniques. Neurology (2004) 1.00
Pediatric language mapping: sensitivity of neurostimulation and Wada testing in epilepsy surgery. Epilepsia (2007) 0.99
Epilepsy and anxiety. Epilepsy Behav (2003) 0.98
Vagus nerve stimulation for children with treatment-resistant epilepsy: a consecutive series of 141 cases. J Neurosurg Pediatr (2011) 0.98
Adult-onset neuronal ceroid lipofuscinosis (Kufs disease) with autosomal dominant inheritance in Alabama. Epilepsia (2003) 0.98
Neuropsychiatric autoimmune encephalitis without VGKC-complex, NMDAR, and GAD autoantibodies: case report and literature review. Cogn Behav Neurol (2013) 0.97
Default mode network abnormalities in idiopathic generalized epilepsy. Epilepsy Behav (2012) 0.96
The case for assessing cannabidiol in epilepsy. Epilepsia (2014) 0.96
Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia. J Neuroimaging (2011) 0.96
Psychotropic effects of antiepileptic drugs. Epilepsy Curr (2005) 0.96
Sequential then interactive processing of letters and words in the left fusiform gyrus. Nat Commun (2012) 0.95
Right ventromedial prefrontal lesions result in paradoxical cardiovascular activation with emotional stimuli. Brain (2006) 0.95
Psychosis in epilepsy patients. Epilepsia (2007) 0.95
Rectal diazepam gel for treatment of acute repetitive seizures in adults. Arch Neurol (2002) 0.94
Vagus nerve stimulation for refractory idiopathic generalised epilepsy. Seizure (2004) 0.94
Structural evidence for involvement of a left amygdala-orbitofrontal network in subclinical anxiety. Psychiatry Res (2011) 0.93
Sexually dimorphic recruitment of spinal opioid analgesic pathways by the spinal application of morphine. J Pharmacol Exp Ther (2007) 0.93
A survey of seizures and current treatments in 15q duplication syndrome. Epilepsia (2014) 0.92
Surgical outcome in tuberous sclerosis complex: a multicenter survey. Epilepsia (2007) 0.92
Postictal psychosis in partial epilepsy: a case-control study. Ann Neurol (2008) 0.92
Electrocorticographic evidence of perituberal cortex epileptogenicity in tuberous sclerosis complex. J Neurosurg Pediatr (2012) 0.91
Extent of ictal origin in mesial temporal sclerosis patients monitored with subdural intracranial electrodes predicts outcome. J Clin Neurophysiol (2003) 0.91
Temporal lobe epilepsy: a progressive disorder? Rev Neurol Dis (2007) 0.91
Multiple subpial transection for intractable partial epilepsy: an international meta-analysis. Epilepsia (2002) 0.90
Cognition-induced epilepsy. Epilepsy Behav (2002) 0.90
Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex. Epilepsy Behav (2013) 0.89
Epilepsy and dental procedures. A review. N Y State Dent J (2008) 0.89
Medically refractory epilepsy in autism. Epilepsia (2011) 0.89
Serum sphingomyelin levels are related to the clearance of postprandial remnant-like particles. J Lipid Res (2004) 0.89
Epileptic kinetopsia: ictal illusory motion perception. Neurology (2003) 0.89
Quantifying deficits in the perception of fear and anger in morphed facial expressions after bilateral amygdala damage. Neuropsychologia (2006) 0.88
Correlation of apparent diffusion coefficient with neuropsychological testing in temporal lobe epilepsy. AJNR Am J Neuroradiol (2005) 0.88
Evolution and prospects for intracranial pharmacotherapy for refractory epilepsies: the subdural hybrid neuroprosthesis. Epilepsy Res Treat (2010) 0.87
Localized transmeningeal muscimol prevents neocortical seizures in rats and nonhuman primates: therapeutic implications. Epilepsia (2008) 0.86
Somatoform disorders after temporal lobectomy. Cogn Behav Neurol (2004) 0.86
Intracranial microprobe for evaluating neuro-hemodynamic coupling in unanesthetized human neocortex. J Neurosci Methods (2009) 0.86
Impaired baroreflex function in temporal lobe epilepsy. J Neurol (2006) 0.86
Epilepsy surgery and tuberous sclerosis complex: special considerations. Neurosurg Focus (2008) 0.86
Volume of the human septal forebrain region is a predictor of source memory accuracy. J Int Neuropsychol Soc (2011) 0.85
In vivo hippocampal metabolic dysfunction in human temporal lobe epilepsy. Arch Neurol (2002) 0.85
PNC-28, a p53-derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo. Int J Cancer (2006) 0.85
Epilepsy surgery in tuberous sclerosis: multistage procedures with bilateral or multilobar foci. J Child Neurol (2002) 0.85
Sex-/ovarian steroid-dependent release of endomorphin 2 from spinal cord. J Pharmacol Exp Ther (2007) 0.85
Bottom-of-sulcus dysplasia: imaging features. AJR Am J Roentgenol (2011) 0.85
Mental retardation and relation to seizure and tuber burden in tuberous sclerosis complex. Seizure (2006) 0.84
Transmeningeal delivery of GABA to control neocortical seizures in rats. Epilepsy Res (2007) 0.84
Evidence of cerebral reorganization following perinatal stroke demonstrated with fMRI and DTI tractography. Clin Imaging (2005) 0.84
Neuroimaging the epileptogenic process. Neurotherapeutics (2014) 0.84